Literature DB >> 31201598

UNC13A variant rs12608932 is associated with increased risk of amyotrophic lateral sclerosis and reduced patient survival: a meta-analysis.

Baiyuan Yang1, Haixia Jiang2, Fang Wang3, Shimei Li4, Chongmin Wu3, Jianjian Bao3, Yongyun Zhu3, Zhong Xu3, Bin Liu3, Hui Ren3, Xinglong Yang5.   

Abstract

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease associated with both genetic and environmental risk factors. Previous studies trying to find an association between ALS and unc-13 homolog A (UNC13A) gene variants have shown inconsistent results. This study aimed to conduct a meta-analysis of the association between the C allele of rs12608932, a single-nucleotide polymorphism located in an intron of UNC13A, and risk of ALS and patient survival.
METHODS: PubMed, Web of Science, Embase, Chinese National Knowledge Infrastructure, Wanfang, and SinoMed databases were systematically searched for genome-wide association studies or case-control studies published up to January 2019 on the association between this variant in UNC13A and risk and/or prognosis of ALS. Data from eligible studies were extracted and analyzed.
RESULTS: The pooled data (28,072 patients with sporadic ALS and 56,545 controls) showed that rs12608932(C) was associated with an increased risk of ALS (OR = 1.13, 95%CI 1.07-1.20). Subgroup analysis revealed that rs12608932(C) increased the risk of sporadic ALS in non-Asian individuals, including those from the USA and Europe (OR 1.17, 95%CI 1.10-1.25, P < 0.000), but not in Japanese or Chinese subjects (OR 1.01, 95%CI 0.92-1.10, P = 0.85). The available data demonstrated that the CC genotype decreased the survival time of patients with ALS (OR 1.33, 95%CI 1.19-1.49, P < 0.001).
CONCLUSION: The present meta-analysis suggests that rs12608932(C) is associated with increased ALS susceptibility, especially in Caucasian and European subjects, and that the CC genotype of rs12608932 is associated with reduced ALS patient survival.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Meta-analysis; Risk; Survival; UNC13A; rs12608932

Mesh:

Substances:

Year:  2019        PMID: 31201598     DOI: 10.1007/s10072-019-03951-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  27 in total

1.  Analysis of the UNC13A gene as a risk factor for sporadic amyotrophic lateral sclerosis.

Authors:  Hussein Daoud; Véronique Belzil; Anne Desjarlais; William Camu; Patrick A Dion; Guy A Rouleau
Journal:  Arch Neurol       Date:  2010-04

Review 2.  Amyotrophic Lateral Sclerosis: An Update for 2018.

Authors:  Björn Oskarsson; Tania F Gendron; Nathan P Staff
Journal:  Mayo Clin Proc       Date:  2018-07-04       Impact factor: 7.616

3.  Meta-analysis: principles and procedures.

Authors:  M Egger; G D Smith; A N Phillips
Journal:  BMJ       Date:  1997-12-06

4.  Genome-wide association analyses in Han Chinese identify two new susceptibility loci for amyotrophic lateral sclerosis.

Authors:  Min Deng; Ling Wei; Xianbo Zuo; Yanghua Tian; Fei Xie; Panpan Hu; Chunyan Zhu; Fengqiong Yu; Yu Meng; Honghao Wang; Fangfang Zhang; Huijuan Ma; Rong Ye; Huaidong Cheng; Jing Du; Wenwen Dong; Shanshan Zhou; Changqing Wang; Yu Wang; Jingye Wang; Xianwen Chen; Zhongwu Sun; Nong Zhou; Yubao Jiang; Xiuxiu Liu; Xiaogang Li; Nan Zhang; Na Liu; Yingjun Guan; Yongsheng Han; Yongzhu Han; Xinyi Lv; Yu Fu; Hui Yu; Chunhua Xi; Dandan Xie; Qiyuan Zhao; Peng Xie; Xin Wang; Zhijun Zhang; Lu Shen; Yong Cui; Xianyong Yin; Hui Cheng; Bo Liang; Xiaodong Zheng; Tatia M C Lee; Gang Chen; Fusheng Zhou; Jan H Veldink; Wim Robberecht; John E Landers; Peter M Andersen; Ammar Al-Chalabi; Chris Shaw; Chunfeng Liu; Beisha Tang; Shangxi Xiao; Janice Robertson; Fengyu Zhang; Leonard H van den Berg; Liangdan Sun; Jianjun Liu; Sen Yang; Xiaodong Ju; Kai Wang; Xuejun Zhang
Journal:  Nat Genet       Date:  2013-04-28       Impact factor: 38.330

5.  Replication analysis of SNPs on 9p21.2 and 19p13.3 with amyotrophic lateral sclerosis in East Asians.

Authors:  Aritoshi Iida; Atsushi Takahashi; Min Deng; Yun Zhang; Jing Wang; Naoki Atsuta; Fumiaki Tanaka; Tetsumasa Kamei; Motoki Sano; Shuichi Oshima; Torao Tokuda; Mitsuya Morita; Chizuru Akimoto; Masahiro Nakajima; Michiaki Kubo; Naoyuki Kamatani; Imaharu Nakano; Gen Sobue; Yusuke Nakamura; Dongsheng Fan; Shiro Ikegawa
Journal:  Neurobiol Aging       Date:  2011-02-03       Impact factor: 4.673

6.  An association study between SCFD1 rs10139154 variant and amyotrophic lateral sclerosis in a Chinese cohort.

Authors:  Yongping Chen; Qingqing Zhou; Xiaojing Gu; Qianqian Wei; Bei Cao; Hui Liu; Yanbing Hou; Huifang Shang
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-12-20       Impact factor: 4.092

7.  UNC13A confers risk for sporadic ALS and influences survival in a Spanish cohort.

Authors:  Jose Manuel Vidal-Taboada; Alan Lopez-Lopez; Maria Salvado; Laura Lorenzo; Cecilia Garcia; Nicole Mahy; Manuel J Rodríguez; Josep Gamez
Journal:  J Neurol       Date:  2015-07-11       Impact factor: 4.849

8.  Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study.

Authors:  Hannu Laaksovirta; Terhi Peuralinna; Jennifer C Schymick; Sonja W Scholz; Shaoi-Lin Lai; Liisa Myllykangas; Raimo Sulkava; Lilja Jansson; Dena G Hernandez; J Raphael Gibbs; Michael A Nalls; David Heckerman; Pentti J Tienari; Bryan J Traynor
Journal:  Lancet Neurol       Date:  2010-10       Impact factor: 44.182

Review 9.  Amyotrophic lateral sclerosis.

Authors:  Orla Hardiman; Ammar Al-Chalabi; Adriano Chio; Emma M Corr; Giancarlo Logroscino; Wim Robberecht; Pamela J Shaw; Zachary Simmons; Leonard H van den Berg
Journal:  Nat Rev Dis Primers       Date:  2017-10-05       Impact factor: 52.329

10.  Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study.

Authors:  Aleksey Shatunov; Kin Mok; Stephen Newhouse; Michael E Weale; Bradley Smith; Caroline Vance; Lauren Johnson; Jan H Veldink; Michael A van Es; Leonard H van den Berg; Wim Robberecht; Philip Van Damme; Orla Hardiman; Anne E Farmer; Cathryn M Lewis; Amy W Butler; Olubunmi Abel; Peter M Andersen; Isabella Fogh; Vincenzo Silani; Adriano Chiò; Bryan J Traynor; Judith Melki; Vincent Meininger; John E Landers; Peter McGuffin; Jonathan D Glass; Hardev Pall; P Nigel Leigh; John Hardy; Robert H Brown; John F Powell; Richard W Orrell; Karen E Morrison; Pamela J Shaw; Christopher E Shaw; Ammar Al-Chalabi
Journal:  Lancet Neurol       Date:  2010-10       Impact factor: 44.182

View more
  9 in total

1.  Rare Neurologic Diseases and Neurological Sciences: a report for the celebration of the 2020 Rare Diseases Day.

Authors:  Antonio Federico
Journal:  Neurol Sci       Date:  2020-03       Impact factor: 3.307

2.  Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: Towards therapeutic targets and biomarkers.

Authors:  Tetsuya Akiyama; Yuka Koike; Leonard Petrucelli; Aaron D Gitler
Journal:  Clin Transl Med       Date:  2022-05

Review 3.  Molecular Mechanisms Linking ALS/FTD and Psychiatric Disorders, the Potential Effects of Lithium.

Authors:  Fiona Limanaqi; Francesca Biagioni; Larisa Ryskalin; Carla L Busceti; Francesco Fornai
Journal:  Front Cell Neurosci       Date:  2019-10-04       Impact factor: 5.505

4.  High-Throughput Genetic Testing in ALS: The Challenging Path of Variant Classification Considering the ACMG Guidelines.

Authors:  Serena Lattante; Giuseppe Marangi; Paolo Niccolò Doronzio; Amelia Conte; Giulia Bisogni; Marcella Zollino; Mario Sabatelli
Journal:  Genes (Basel)       Date:  2020-09-24       Impact factor: 4.096

5.  TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A.

Authors:  Anna-Leigh Brown; Oscar G Wilkins; Matthew J Keuss; Sarah E Hill; Matteo Zanovello; Weaverly Colleen Lee; Alexander Bampton; Flora C Y Lee; Laura Masino; Yue A Qi; Sam Bryce-Smith; Ariana Gatt; Martina Hallegger; Delphine Fagegaltier; Hemali Phatnani; Jia Newcombe; Emil K Gustavsson; Sahba Seddighi; Joel F Reyes; Steven L Coon; Daniel Ramos; Giampietro Schiavo; Elizabeth M C Fisher; Towfique Raj; Maria Secrier; Tammaryn Lashley; Jernej Ule; Emanuele Buratti; Jack Humphrey; Michael E Ward; Pietro Fratta
Journal:  Nature       Date:  2022-02-23       Impact factor: 69.504

6.  TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A.

Authors:  X Rosa Ma; Mercedes Prudencio; Yuka Koike; Sarat C Vatsavayai; Garam Kim; Fred Harbinski; Adam Briner; Caitlin M Rodriguez; Caiwei Guo; Tetsuya Akiyama; H Broder Schmidt; Beryl B Cummings; David W Wyatt; Katherine Kurylo; Georgiana Miller; Shila Mekhoubad; Nathan Sallee; Gemechu Mekonnen; Laura Ganser; Jack D Rubien; Karen Jansen-West; Casey N Cook; Sarah Pickles; Björn Oskarsson; Neill R Graff-Radford; Bradley F Boeve; David S Knopman; Ronald C Petersen; Dennis W Dickson; James Shorter; Sua Myong; Eric M Green; William W Seeley; Leonard Petrucelli; Aaron D Gitler
Journal:  Nature       Date:  2022-02-23       Impact factor: 69.504

7.  Genetic factors for survival in amyotrophic lateral sclerosis: an integrated approach combining a systematic review, pairwise and network meta-analysis.

Authors:  Wei-Ming Su; Xiao-Jing Gu; Qing-Qing Duan; Zheng Jiang; Xia Gao; Hui-Fang Shang; Yong-Ping Chen
Journal:  BMC Med       Date:  2022-06-27       Impact factor: 11.150

8.  High-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: A pilot study.

Authors:  Raul Juntas-Morales; Nicolas Pageot; Abdelkarim Bendarraz; Sébastien Alphandéry; Frédéric Sedel; Stéphanie Seigle; William Camu
Journal:  EClinicalMedicine       Date:  2020-01-27

Review 9.  From Multi-Omics Approaches to Precision Medicine in Amyotrophic Lateral Sclerosis.

Authors:  Giovanna Morello; Salvatore Salomone; Velia D'Agata; Francesca Luisa Conforti; Sebastiano Cavallaro
Journal:  Front Neurosci       Date:  2020-10-30       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.